DPIIT recognised startup Government of India
Startup India
Nalkem Pharma Private Limited
Nalkem Pharma Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.02 Cr
▼ 72% YoY
Net profit · FY 2025
₹1.17 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹4.38 Lakh
EBITDA margin 4.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Nalkem Pharma Private Limited
Data last updated:
Nalkem Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2021PTC153370. Its GSTIN is 36AAHCN7121P1Z0 (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Jaya Bhanu Venkata Nageswara Rao Nalla (Managing Director) and Venkata Laxmi Lakkimsetty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 – 4 – 12/2/409 Sai Heights Block – 2 Turkapally Bolarum Alwal, Secunderabad, Telangana, India – 500010.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.02 Cr, a decline of 72% compared to the previous year. For the same year it recorded a net profit of ₹1.17 Lakh (net margin 1.1%) and EBITDA of ₹4.38 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
Nalkem Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0021789).
Company details
CIN U24304TG2021PTC153370
Registration Number 153370
Incorporation Date 22 July 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0021789
Key People
Jaya Bhanu Venkata Nageswara Rao Nalla Managing Director Venkata Laxmi Lakkimsetty Director Recognitions & Rankings of Nalkem Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-20-0021789
Contact details
Nalkem Pharma Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3 – 4 – 12/2/409 Sai Heights Block – 2 Turkapally Bolarum Alwal, Secunderabad, Telangana, India – 500010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nalkem Pharma Private Limited, buy the company report.
Comprehensive company report
Nalkem Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nalkem Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nalkem Pharma Private Limited, buy the company report.
Financials of Nalkem Pharma Private Limited
FY 2025 filings availableNalkem Pharma Private Limited reported revenue of ₹1.02 Cr (down 72% YoY) for FY 2025.
Revenue · FY 2025
₹1.02 Cr ▼ 72%
Net profit · FY 2025
₹1.17 Lakh margin 1.1%
EBITDA · FY 2025
₹4.38 Lakh margin 4.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 72%
3 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▼ 83%
3 years · compounded
▲ 78%
Revenue fell 72% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 16%. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹4.38 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.17 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.3% | |||
| Net Profit Margin | 1.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Nalkem Pharma Private Limited, buy the company report.
Board of directors of Nalkem Pharma Private Limited
Nalkem Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Laxmi Lakkimsetty Also directs: Nalkem Pharmaceuticals India Private Limited | Director | 22 Jul 2021 | 5 Years 3 Months | Current |
| Jaya Bhanu Venkata Nageswara Rao Nalla Also directs: Nalkem Pharmaceuticals India Private Limited | Managing Director | 22 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Nalkem Pharma Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sap Sale Promotion Private Limited | ₹1.02 Cr (FY 2025) | -10.0% | Delhi, India | |||
| Yrc Pharmaa Merchant Private Limited | ₹1.02 Cr (FY 2024) | Lucknow, Uttar Pradesh, India | ||||
| 4Life Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | 22.0% | Jaipur, Rajasthan, India | |||
| Dhiraj Diamond Tools Private Limited | ₹1.02 Cr (FY 2025) | -11.0% | Ahmedabad, Gujarat, India | |||
| Chemspirit Instruments & Technologies Private Limited | ₹1.02 Cr (FY 2024) | -8.0% | Selaiyur, Tamil Nadu, India | |||
| Nalkem Pharma Private Limitedthis company | ₹1.02 Cr (FY 2025) | ₹1.17 Lakh | 1.1% | -72.0% | Secunderabad, Telangana, India | |
| Badiberi Trading Private Limited | ₹1.02 Cr (FY 2025) | 658.0% | Kolkata, West Bengal, India | |||
| Sankalap Ferromet Private Limited | ₹1.02 Cr (FY 2020) | -87.0% | Mumbai, Maharashtra, India | |||
| Medigenesis Pharma Private Limited | ₹1.02 Cr (FY 2024) | 20.0% | Delhi, India | |||
| Evo Life Sciences Private Limited | ₹1.02 Cr (FY 2023) | 770.0% | Rohtak, Haryana, India |
To see the full peer comparison of Nalkem Pharma Private Limited, buy the company report.
Auditor
Nalkem Pharma Private Limited is audited by MANKALA AND CHIKKALA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANKALA AND CHIKKALA | FY 2023 | 016019S |
Shareholding
The shareholding of Nalkem Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Nalkem Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nalkem Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nalkem Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nalkem Pharma Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
Active EPFO establishments
1
GST
Nalkem Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCN7121P1Z0 | Telangana | Active | 24 Sep 2021 |
To see the full GST registrations and return filing status of Nalkem Pharma Private Limited, buy the company report.
Recent activity
Nalkem Pharma Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Manju Jain ceased to be Director on 08 Dec 2023.
AGM
Nalkem Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nalkem Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Manju Jain ceased to be Director.
Ceased
Venkateshwar Gundaboina ceased to be Director.
Ceased
Samba Sivarao Arigela ceased to be Director.
Appointed
Jaya Bhanu Venkata Nageswara Rao Nalla was appointed as Managing Director.
Appointed
Venkata Laxmi Lakkimsetty was appointed as Director.
Incorporation
22 Jul 2021
Nalkem Pharma Private Limited was registered on 22 Jul 2021 with Roc Hyderabad & aged 5 years 3 months as per MCA records.
Frequently asked questions
Nalkem Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 July 2021 (5+ years old) and is registered under CIN U24304TG2021PTC153370.
Nalkem Pharma has 2 current directors:
- Jaya Bhanu Venkata Nageswara Rao Nalla - Managing Director
- Venkata Laxmi Lakkimsetty - Director
The latest financial statements of Nalkem Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Nalkem Pharma is 36AAHCN7121P1Z0, registered in Telangana.
The CIN (Corporate Identification Number) of Nalkem Pharma is U24304TG2021PTC153370. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nalkem Pharma was incorporated on 22 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Nalkem Pharma by revenue are Sap Sale Promotion Private Limited, Yrc Pharmaa Merchant Private Limited, 4Life Pharmaceuticals Private Limited, Dhiraj Diamond Tools Private Limited, Chemspirit Instruments & Technologies Private Limited and 4 more, all in the same principal business activity (wholesale trading).
Manju Jain ceased to be Director on 08 Dec 2023. Venkateshwar Gundaboina ceased to be Director on 17 Apr 2023. Samba Sivarao Arigela ceased to be Director on 07 Jan 2022. Nalkem Pharma has 5 board changes on record in total.
Yes, Nalkem Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Nalkem Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0021789).
The registered office of Nalkem Pharma is at 3 – 4 – 122409 Sai Heights Block – 2 Turkapally Bolarum Alwal, Secunderabad, Telangana, India – 500010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages